In a study of 38 patients with different tumor types (non-Hodgkin lymphoma (NHL) n = 31; non-small-cell lung carcinoma (NSCLC) n = 4; head and neck squamous cell carcinomas n = 3) treated with various modalities of therapy, 99mTc-Annexin V scintigraphy was acquired before and early after the start of treatment [27]. Here, ANXA5 is linked to non-Hodgkin lymphoma.